Qiagen NV | QIA - Assets

Stock Price
35.83
Daily Change
0.14 0.39%
Monthly
-13.29%
Yearly
-1.94%
Q1 Forecast
35.13

Qiagen NV reported $6.3B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
argenx SE USD 7.18B 973.07M Jun/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Moderna USD 12.34B 203M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Qiagen NV USD 6.3B 257.54M Dec/2025
Revvity USD 12.17B 29.46M Dec/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Viatris USD 37.19B 727.3M Dec/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025